Harborside
Heritage Cannabis Announces Nine New Product Launches in the Ontario Cannabis Market, Including Flower, Pre-rolls and Concentrates

TORONTO–(BUSINESS WIRE)–Heritage Cannabis Holdings Corp. (CSE: CANN) (OTCQX: HERTF) (“Heritage” or the “Company”), today announced the upcoming launch of nine new products that will be available in the Ontario cannabis market through the Ontario Cannabis Store (“OCS”) and retailers in the province. New products include two infused pre-rolls, three concentrates, one pre-roll, two vape cartridges, and one flower product.

Under a recent call for new products, Heritage submitted unique and innovative products for consideration by the OCS, nine of which will be available in Spring of this year – a notable achievement for the Heritage product innovation team.

“Heritage prides itself on creating exceptional products that become disruptors in their respective categories, and this spring our Ontario based followers will have nine new high-demand, well priced products to choose from,” stated David Schwede, CEO of Heritage. “We are a leader in product innovation using our unique processes and technologies that translate into high-growth, healthy margin products for our business, and offer a portfolio of unique and popular products for our consumers.”


  Subscribe to news from
Heritage Cannabis Holdings

Be the first to know when breaking news are released.



About Heritage Cannabis Holdings Corp.

Heritage Cannabis is a leading cannabis company offering innovative products to both the medical and recreational legal cannabis markets in Canada and the U.S., operating under two licensed manufacturing facilities in Canada. The company has an extensive portfolio of high-quality cannabis products under the brands Purefarma, Pura Vida, RAD, Premium 5, feelgood., the CB4 suite of medical products in Canada and ArthroCBD in the U.S.

ON BEHALF OF THE BOARD OF DIRECTORS OF HERITAGE CANNABIS HOLDINGS CORP.

“David Schwede”

David Schwede

CEO

The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.